These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10678345)

  • 21. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
    Ballard CG; Margallo-Lana ML
    J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of medications in treating the behavioural disturbances of dementia sufferers.
    Jackson LD
    Perspectives; 1995; 19(3):9-22. PubMed ID: 7572001
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
    J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steps to managing difficult behavior in people with dementia.
    Han LF; Davidson HE; Gravenstein S
    Med Health R I; 2009 May; 92(5):182-4. PubMed ID: 19530485
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 30. Risperdal advertising in JAGS. Journal of the American Geriatrics Society.
    Beers MH
    J Am Geriatr Soc; 1999 Mar; 47(3):377. PubMed ID: 10078907
    [No Abstract]   [Full Text] [Related]  

  • 31. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior that is difficult to manage and psychological interventions].
    Diesfeldt HF
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):98-9. PubMed ID: 16078655
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
    Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
    J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
    Kálmán J; Kálmán S; Pákáski M
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease.
    Meguro K; Meguro M; Tanaka Y; Akanuma K; Yamaguchi K; Itoh M
    J Geriatr Psychiatry Neurol; 2004 Jun; 17(2):61-7. PubMed ID: 15157345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychiatric disorders and macroprolactinoma].
    Pérez-Camarero E; Martí-Cabané J; Idígoras-Juaristi I; Antón-Aranda E
    Rev Neurol; 1999 Sep 16-30; 29(6):590-1. PubMed ID: 10584279
    [No Abstract]   [Full Text] [Related]  

  • 40. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.